NO2718725T3 - - Google Patents
Info
- Publication number
- NO2718725T3 NO2718725T3 NO12728976A NO12728976A NO2718725T3 NO 2718725 T3 NO2718725 T3 NO 2718725T3 NO 12728976 A NO12728976 A NO 12728976A NO 12728976 A NO12728976 A NO 12728976A NO 2718725 T3 NO2718725 T3 NO 2718725T3
- Authority
- NO
- Norway
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2442—Chitinase (3.2.1.14)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
- G01N2405/08—Sphingolipids
- G01N2405/10—Glycosphingolipids, e.g. cerebrosides, gangliosides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11004597A EP2533051A1 (en) | 2011-06-06 | 2011-06-06 | Method for the diagnosis of Gaucher's disease |
| EP12728976.7A EP2718725B1 (en) | 2011-06-06 | 2012-06-06 | Method for the diagnosis of gaucher's disease |
| PCT/EP2012/002409 WO2012167925A1 (en) | 2011-06-06 | 2012-06-06 | Method for the diagnosis of gaucher's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2718725T3 true NO2718725T3 (enExample) | 2018-05-12 |
Family
ID=44652046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO12728976A NO2718725T3 (enExample) | 2011-06-06 | 2012-06-06 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10859580B2 (enExample) |
| EP (4) | EP2533051A1 (enExample) |
| JP (2) | JP6120832B2 (enExample) |
| CN (1) | CN103582818B (enExample) |
| AU (2) | AU2012266768B2 (enExample) |
| BR (1) | BR112013031431B1 (enExample) |
| CA (1) | CA2837609C (enExample) |
| DK (2) | DK2718725T3 (enExample) |
| ES (2) | ES2820361T3 (enExample) |
| IL (2) | IL229607B (enExample) |
| NO (1) | NO2718725T3 (enExample) |
| PL (2) | PL2718725T3 (enExample) |
| PT (2) | PT2718725T (enExample) |
| RU (1) | RU2666952C2 (enExample) |
| WO (1) | WO2012167925A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2932274B1 (en) * | 2012-12-11 | 2020-01-15 | Centogene AG | Method for the diagnosis of metachromatic leukodystrophy |
| WO2015121855A1 (en) * | 2014-02-11 | 2015-08-20 | Yeda Research And Development Co. Ltd. | Marker of neuropathic gaucher's disease and methods of use thereof |
| CN105463085A (zh) * | 2015-12-11 | 2016-04-06 | 上海新培晶医学检验所有限公司 | 一种检测戈谢病gba基因突变的试剂盒及其检测方法 |
| EP3264092A1 (en) | 2016-07-01 | 2018-01-03 | Centogene AG | Use of lyso-gb1 as druggable target |
| RU2629626C1 (ru) * | 2016-10-05 | 2017-08-30 | Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) | Способ оценки эффективности лечения болезни Гоше у детей |
| KR20230129426A (ko) | 2020-12-08 | 2023-09-08 | 토드 프랭크 오보케이티스 | 줄기 세포 생산 증가를 위한 방법 및 시스템 |
| IL317112A (en) * | 2022-06-01 | 2025-01-01 | Univ Antwerpen | Method for detecting biomarkers of lysosomal storage disease and kits for performing the method |
| WO2024211616A1 (en) * | 2023-04-04 | 2024-10-10 | Ovokaitys Todd Frank | Methods and systems for improved therapies of genetic diseases using photo-activated allogenic stem cells |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5236838A (en) | 1988-12-23 | 1993-08-17 | Genzyme Corporation | Enzymatically active recombinant glucocerebrosidase |
| UA63743A (en) * | 2003-06-09 | 2004-01-15 | Kyiv P Shupyk Medical Academy | Method for diagnosing gaucher disease |
| EP1528056A1 (en) | 2003-10-29 | 2005-05-04 | Academisch Ziekenhuis bij de Universiteit van Amsterdam | Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors |
| CN104771402A (zh) * | 2005-06-08 | 2015-07-15 | 阿米库斯治疗学公司 | 溶酶体酶编码基因突变相关的cns紊乱的治疗 |
| EP2040548B1 (en) * | 2006-06-23 | 2012-05-02 | Amicus Therapeutics, Inc. | Method for the treatment of neurological disorders by enhancing the activity of beta -glucocerebrosidase |
| WO2008128106A1 (en) | 2007-04-13 | 2008-10-23 | Amicus Therapeutics, Inc. | Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers |
| WO2008134628A2 (en) * | 2007-04-26 | 2008-11-06 | Amicus Therapeutics, Inc. | Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones |
| HUE027278T2 (en) | 2007-05-16 | 2016-11-28 | Brigham & Womens Hospital Inc | Treatment of synucleinopathies |
| CA2745451A1 (en) * | 2008-11-14 | 2010-05-20 | Parkinson's Institute | Compositions and methods for the treatment of altered a-synuclein function |
-
2011
- 2011-06-06 EP EP11004597A patent/EP2533051A1/en not_active Withdrawn
-
2012
- 2012-06-06 EP EP17206796.9A patent/EP3318881B1/en not_active Revoked
- 2012-06-06 EP EP20185233.2A patent/EP3742168A1/en not_active Withdrawn
- 2012-06-06 NO NO12728976A patent/NO2718725T3/no unknown
- 2012-06-06 PL PL12728976T patent/PL2718725T3/pl unknown
- 2012-06-06 ES ES17206796T patent/ES2820361T3/es active Active
- 2012-06-06 AU AU2012266768A patent/AU2012266768B2/en not_active Ceased
- 2012-06-06 WO PCT/EP2012/002409 patent/WO2012167925A1/en not_active Ceased
- 2012-06-06 CA CA2837609A patent/CA2837609C/en active Active
- 2012-06-06 PT PT127289767T patent/PT2718725T/pt unknown
- 2012-06-06 RU RU2013158667A patent/RU2666952C2/ru active
- 2012-06-06 ES ES12728976.7T patent/ES2659753T3/es active Active
- 2012-06-06 DK DK12728976.7T patent/DK2718725T3/en active
- 2012-06-06 JP JP2014513942A patent/JP6120832B2/ja not_active Expired - Fee Related
- 2012-06-06 PL PL17206796T patent/PL3318881T3/pl unknown
- 2012-06-06 PT PT172067969T patent/PT3318881T/pt unknown
- 2012-06-06 US US14/124,375 patent/US10859580B2/en not_active Expired - Fee Related
- 2012-06-06 DK DK17206796.9T patent/DK3318881T3/da active
- 2012-06-06 CN CN201280027860.3A patent/CN103582818B/zh not_active Expired - Fee Related
- 2012-06-06 EP EP12728976.7A patent/EP2718725B1/en not_active Revoked
- 2012-06-06 BR BR112013031431-1A patent/BR112013031431B1/pt not_active IP Right Cessation
-
2013
- 2013-11-25 IL IL229607A patent/IL229607B/en active IP Right Grant
-
2017
- 2017-03-28 JP JP2017062025A patent/JP6514256B2/ja not_active Expired - Fee Related
- 2017-09-25 AU AU2017232226A patent/AU2017232226B2/en not_active Ceased
-
2018
- 2018-04-30 US US15/966,734 patent/US11092609B2/en not_active Expired - Fee Related
- 2018-06-17 IL IL260078A patent/IL260078B/en active IP Right Grant
-
2021
- 2021-07-20 US US17/380,257 patent/US20220011321A1/en not_active Abandoned